Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Celltrion Considers US Manufacturing In Response To Trump Tariffs
Measures Also Include Securing US Inventory And Focus On Drug Substance Imports
Jan 30 2025
•
By
Dave Wallace
Celltrion has plans to deal with any US tariffs
(Shutterstock)
More from Strategy
More from Policy & Regulation